DRNA Gross Margin

The Gross Margin of Dicerna Pharmaceuticals Inc (DRNA) is N/A.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

DRNA Gross Margin - Peers Comparison

Ticker	Name	Value
DMTK	DermTech Inc	1.80%
SGMO	Sangamo Therapeutics Inc	7775.20%
950220.KQ	Neoimmunetech Inc	7775.20%
GBT	Global Blood Therapeutics Inc	98.30%
IMGN	ImmunoGen Inc	99.82%
ABBV	Abbvie Inc	69.99%
GBIO	Generation Bio Co	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
ZYME	Zymeworks Inc	7775.20%
BCAB	Bioatla Inc	7775.20%
GILD	Gilead Sciences Inc	78.26%
NRIX	Nurix Therapeutics Inc	7775.20%
PMVP	PMV Pharmaceuticals Inc	7775.20%
RGNX	Regenxbio Inc	59.72%
CCCC	C4 Therapeutics Inc	7775.20%
BLUE	bluebird bio Inc	-6.65%
OLMA	Olema Pharmaceuticals Inc	7775.20%
RCUS	Arcus Biosciences Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
950200.KQ	Psomagen Inc	23.13%
AMGN	Amgen Inc	68.71%
CYTK	Cytokinetics Inc	7775.20%
KURA	Kura Oncology Inc	7775.20%
ALEC	Alector Inc	7775.20%
MCRB	Seres Therapeutics Inc	7775.20%
MRNA	Moderna Inc	70.06%
RUBY	Rubius Therapeutics Inc	7775.20%
CGEM	Cullinan Oncology Inc	7775.20%
ADCT	ADC Therapeutics SA	91.60%
ALVR	Allovir Inc	7775.20%
INO	Inovio Pharmaceuticals Inc	60.13%
MYOV	Myovant Sciences Ltd	77.68%
QURE	Uniqure NV	32.42%
950160.KQ	Kolon TissueGene Inc	11.72%